(Q51071410)

28 March 2018

title

At low doses ethanol maintains blood-brain barrier (BBB) integrity after hypoxia and reoxygenation: a brain slice study. (English)

1 reference

28 March 2018

1 reference

Changya Peng

1

1 reference

28 March 2018

William A Li

2

1 reference

28 March 2018

Paul Fu

3

1 reference

28 March 2018

Tia Chakraborty

4

1 reference

28 March 2018

Mohammed Hussain

5

1 reference

28 March 2018

Murali Guthikonda

6

1 reference

28 March 2018

Jose A Rafols

7

1 reference

28 March 2018

Yuchuan Ding

8

1 reference

28 March 2018

publication date

12 April 2013

1 reference

28 March 2018

published in

Neurological Research

1 reference

28 March 2018

volume

35

1 reference

28 March 2018

issue

8

1 reference

28 March 2018

page(s)

790-797

1 reference

28 March 2018

Structure and function of the blood-brain barrier

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Edema formation in the hyperacute phase of ischemic stroke. Laboratory investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Blood-brain barrier tight junction permeability and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Acute ethanol treatment reduces blood-brain barrier dysfunction following ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

MRI detection of early blood-brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Mmp-9, a potential target for cerebral ischemic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Role of aquaporin-4 in cerebral edema and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Hypoxia-inducible factor-1α contributes to brain edema after stroke by regulating aquaporins and glycerol distribution in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Aquaporins in the brain: from aqueduct to "multi-duct".

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Aquaglyceroporin 9 in brain pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Brain ethanol levels in rats after voluntary ethanol consumption using a sweetened gelatin vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Brain ethanol concentrations and ethanol discrimination in rats: effects of dose and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Ethanol reduces metabolic uncoupling following experimental head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Effects of moderate alcohol consumption on the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Ethanol reduces expression of apoptotic proteins after hypoxia/reoxygenation in a brain slice model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Aquaporins in cerebrovascular disease: a target for treatment of brain edema?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Time course of aquaporin expression after transient focal cerebral ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Aquaporins in brain: distribution, physiology, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

The molecular basis of water transport in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

New insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Verification of enhancement of the CSF space, not parenchyma, in acute stroke patients with early blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Extracellular matrix-degrading proteinases in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Increased brain microvascular MMP-9 and incidence of haemorrhagic transformation in obese mice after experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Inflammation in stroke and focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Comparison of matrix metalloproteinase activation after focal cortical ischemia in young adult and aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Association between alcohol and mortality in patients with severe traumatic head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Caspase-3 contributes to ZO-1 and Cl-5 tight-junction disruption in rapid anoxic neurovascular unit damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Microvascular oxygenation and oxidative stress during postischemic reperfusion. PO2, ROS, and NO during reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Acute ethanol effects on focal cerebral ischemia in fasted rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Alcohol-induced interactive phosphorylation of Src and toll-like receptor regulates the secretion of inflammatory mediators by human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

The inflammatory footprints of alcohol-induced oxidative damage in neurovascular components

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

Biochemical Markers for Blood-Brain Barrier Dysfunction in Acute Ischemic Stroke Correlate with Evolution and Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000198

10.1179/1743132813Y.0000000198

21 January 2018

Identifiers

DOI

1 reference

28 March 2018

PubMed ID

23582053

1 reference

28 March 2018